Company profile: EnginZyme
1.1 - Company Overview
Company description
- Provider of a patented cell-free biomanufacturing platform and services for the sustainable production of common goods. Offers EziG immobilized enzyme cascades enabling continuous, organism-free operation; automated biocatalyst design; integrated bioprocess engineering and scale-up from catalyst design to commercialization; and a patented enzymatic pseudouridine synthesis for mRNA vaccines.
Products and services
- Cell-free biomanufacturing platform: EnginZyme architects an industrial-grade enzyme immobilization system that creates solid biocatalysts enabling continuous operation in chemical industry reactors without living organisms, advancing sustainable production of common goods
- EziG: EnginZyme engineers a modular technology immobilizing enzyme cascades on solid supports, producing stable, reusable biocatalysts for chemical synthesis to enable greener, efficient manufacturing
- Integrated solutions: EnginZyme delivers custom-engineered bioprocess engineering services from catalyst design to process scale-up to commercialize sustainable biomanufacturing processes for common goods, coordinating development and scale-up into industrial production
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to EnginZyme
BioDtech
HQ: United States
Website
- Description: Provider of reagents and systems for the detection, neutralization, and removal of endotoxin for researchers in bioresearch and bioprocess markets, offering detection solutions including EndoDtec-F to uncover bacteria in environmental samples, injectable drugs, and medical devices.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full BioDtech company profile →
Prism Pharma
HQ: United States
Website
- Description: Provider of cardiovascular injectable products for acute care, developing and commercializing therapies in the United States, including NEXTERONE, an antiarrhythmic injectable amiodarone, and PM103, an intravenous clopidogrel bisulfate.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Prism Pharma company profile →
Phasefocus
HQ: United Kingdom
Website
- Description: Provider of Virtual Lens and ptychographic imaging technologies that generate high-definition amplitude and phase images without high-quality lenses for optical, X-ray and electron microscopy. Products include Livecyte, a label-free system to track and analyze live cell behavior, and πBox, a ptychographic reconstruction engine for electron microscopy.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Phasefocus company profile →
Camurus
HQ: Sweden
Website
- Description: Provider of innovative specialty medicines, with research-based development and commercialization aimed at improving treatment outcomes and quality of life for patients with serious and chronic diseases; based in Lund.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Camurus company profile →
Groupe Carso
HQ: France
Website
- Description: Provider of environmental and agrifood analytical services, including testing of water and environmental elements (soils, waste, biomass, emissions, air quality), food and animal nutrition sampling and analyses, industrial hygiene and building health services (chemical risk, pollutant concentrations, radioprotection), forensic analyses (genetic/digital fingerprinting, blood trace, electronic/computer evidence), high-throughput DNA sequencing, and lab outsourcing support.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Groupe Carso company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for EnginZyme
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to EnginZyme
2.2 - Growth funds investing in similar companies to EnginZyme
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for EnginZyme
4.2 - Public trading comparable groups for EnginZyme
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →